| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Chemosensitisation of PDAC cell lines by the VCP inhibitor NMS-873
|
Astuti, Yuliana
|
|
2016
|
16 |
3S |
p. S7-
1 p.
|
article
|
| 2 |
Circulating biomarkers in pancreatic cancer
|
Brady, Ged
|
|
2016
|
16 |
3S |
p. S2-
1 p.
|
article
|
| 3 |
Developing drug combinations to co-target pancreatic cancer and its supporting stroma
|
Carapuça, Elisabete F.
|
|
2016
|
16 |
3S |
p. S4-
1 p.
|
article
|
| 4 |
In vitro models of drug screening for pancreatic cancer
|
Lam, Hoyin
|
|
2016
|
16 |
3S |
p. S8-
1 p.
|
article
|
| 5 |
Killing cancers by targeting their engines, not their drivers
|
Evan, Gerard
|
|
2016
|
16 |
3S |
p. S6-S7
2 p.
|
article
|
| 6 |
Modifying oncolytic viral therapy for pancreatic cancer
|
Man, Y.K. Stella
|
|
2016
|
16 |
3S |
p. S4-
1 p.
|
article
|
| 7 |
Nanomedicine in pancreatic cancer – A way forward?
|
Mayerle, Julia
|
|
2016
|
16 |
3S |
p. S5-S6
2 p.
|
article
|
| 8 |
Novel roles for de-aminating enzymes in pancreatic cancer
|
Rhim, Andrew D.
|
|
2016
|
16 |
3S |
p. S5-
1 p.
|
article
|
| 9 |
Pancreatic cancer research fund tissue bank
|
Ambily, Archana
|
|
2016
|
16 |
3S |
p. S3-
1 p.
|
article
|
| 10 |
PET-CT in pancreatic cancer
|
Ghaneh, Paula
|
|
2016
|
16 |
3S |
p. S2-S3
2 p.
|
article
|
| 11 |
PI3K/mTOR/MEK-targeted therapies in pancreatic and ovarian cancers
|
Burmi, Rajpal S.
|
|
2016
|
16 |
3S |
p. S7-
1 p.
|
article
|
| 12 |
SCALOP-2: A multi-centre randomised study of induction chemotherapy followed by capecitabine (± nelfinavir) with high or standard dose radiotherapy for locally advanced non-metastatic pancreatic cancer
|
Mukherjee, Somnath
|
|
2016
|
16 |
3S |
p. S3-S4
2 p.
|
article
|
| 13 |
STAR_PAC: A Phase 1B study repurposing ATRA as stromal targeting agent along with gemcitabine and nab¬Paclitaxel for pancreatic cancer
|
Kocher, Hemant
|
|
2016
|
16 |
3S |
p. S4-S5
2 p.
|
article
|
| 14 |
Targeting DNA damage response pathways to modulate pancreatic ductal adenocarcinoma sensitivity to DNA damaging agents
|
Maginn, Elaina N.
|
|
2016
|
16 |
3S |
p. S8-
1 p.
|
article
|
| 15 |
Targeting pancreatic cancer stem cells
|
Heeschen, Christopher
|
|
2016
|
16 |
3S |
p. S5-
1 p.
|
article
|
| 16 |
The integrin αvβ6 is a promising therapeutic target for treating PDAC
|
Marshall, John
|
|
2016
|
16 |
3S |
p. S6-
1 p.
|
article
|
| 17 |
The role of EUS sampling in the management of all lesions affecting the pancreas
|
Hariharan, Deepak
|
|
2016
|
16 |
3S |
p. S7-S8
2 p.
|
article
|
| 18 |
The role of image guided sampling in the management of solid, cystic and mixed lesions affecting the pancreas
|
Hariharan, Deepak
|
|
2016
|
16 |
3S |
p. S7-
1 p.
|
article
|
| 19 |
Urine biomarkers in pancreatic cancer
|
Crnogorac-Jurcevic, Tatjana
|
|
2016
|
16 |
3S |
p. S2-
1 p.
|
article
|
| 20 |
VOCAL: Virtual online consultations-advantages and limitations
|
Wherton, Joseph
|
|
2016
|
16 |
3S |
p. S3-
1 p.
|
article
|
Journal description